Literature DB >> 24866403

Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response.

Yunlan Du1, Fei Wang1, Jing Zou1, Weidong Le2, Qing Dong1, Zhiying Wang1, Fei Shen1, Ling Yu1, Yansheng Li3.   

Abstract

Abnormal aggregation of α-synuclein (α-syn) is central to the pathogenesis of Parkinson's disease (PD). Histone deacetylase 6 (HDAC6) was previously shown to control major cell response pathways to the cytotoxic ubiquitinated aggregates in some protein aggregation diseases. Whether it influences the aggregation process of α-syn in PD models and its related mechanisms are not completely known. Here, we characterized the expression and function of HDAC6 in the ubiquitin-proteasome system impairment-induced PD model. Our results showed that HDAC6 inhibition further exacerbated the nigrostriatal dopamine neurodegeneration and upregulated α-syn oligomers levels, whereas HDAC6 overexpression in vitro showed the opposite effects. More importantly, we provided evidence for the first time that HDAC6 regulating α-syn oligomers levels were related to its ability to trigger the heat shock response in a heat shock protein 90-dependent manner. HDAC6 mediated the dissociation of heat shock protein 90-heat shock factor 1-containing complex, and the activation of heat shock factor 1, which led to the expression of major molecular chaperones to prevent the deleterious α-syn aggregation. Thus, we propose that HDAC6 appears as a key modulator of cell protective response to the cytotoxic α-syn aggregates and may serve as a potential target for therapy development in PD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heat shock; Histone deacetylase 6; Parkinson's disease; Ubiquitin-proteasome system; α-synuclein

Mesh:

Substances:

Year:  2014        PMID: 24866403     DOI: 10.1016/j.neurobiolaging.2014.04.029

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

Review 1.  Complex neuroprotective and neurotoxic effects of histone deacetylases.

Authors:  Elizabeth A Thomas; Santosh R D'Mello
Journal:  J Neurochem       Date:  2018-04-06       Impact factor: 5.372

Review 2.  Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.

Authors:  Lisa Klingelhoefer; Heinz Reichmann
Journal:  Nat Rev Neurol       Date:  2015-10-27       Impact factor: 42.937

3.  Role of Altered Expression, Activity and Sub-cellular Distribution of Various Histone Deacetylases (HDACs) in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

Authors:  Arpna Srivastava; Jyotirmoy Banerjee; Vivek Dubey; Manjari Tripathi; P Sarat Chandra; M C Sharma; Sanjeev Lalwani; Fouzia Siraj; Ramesh Doddamani; Aparna Banerjee Dixit
Journal:  Cell Mol Neurobiol       Date:  2020-11-28       Impact factor: 5.046

Review 4.  The Proteasome Inhibition Model of Parkinson's Disease.

Authors:  Eduard Bentea; Lise Verbruggen; Ann Massie
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

Review 5.  Alpha-synuclein oligomers: a new hope.

Authors:  Nora Bengoa-Vergniory; Rosalind F Roberts; Richard Wade-Martins; Javier Alegre-Abarrategui
Journal:  Acta Neuropathol       Date:  2017-08-12       Impact factor: 17.088

Review 6.  The class II histone deacetylases as therapeutic targets for Parkinson's disease.

Authors:  Martina Mazzocchi; Louise M Collins; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Neuronal Signal       Date:  2020-06-09

Review 7.  Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation.

Authors:  Yufei Liu; Long Niu; Xinyao Liu; Cheng Cheng; Weidong Le
Journal:  Neurosci Bull       Date:  2021-06-15       Impact factor: 5.271

8.  HDAC6 Regulates the Chaperone-Mediated Autophagy to Prevent Oxidative Damage in Injured Neurons after Experimental Spinal Cord Injury.

Authors:  Min Su; Huaqing Guan; Fan Zhang; Yarong Gao; Xiaomei Teng; Weixin Yang
Journal:  Oxid Med Cell Longev       Date:  2015-11-15       Impact factor: 6.543

9.  HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination.

Authors:  Martin G Strebl; Arthur J Campbell; Wen-Ning Zhao; Frederick A Schroeder; Misha M Riley; Peter S Chindavong; Thomas M Morin; Stephen J Haggarty; Florence F Wagner; Tobias Ritter; Jacob M Hooker
Journal:  ACS Cent Sci       Date:  2017-09-06       Impact factor: 14.553

Review 10.  The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology.

Authors:  Destiny-Love Manecka; Benoît Vanderperre; Edward A Fon; Thomas M Durcan
Journal:  Front Mol Neurosci       Date:  2017-09-27       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.